Off-label treatment in diabetic retinopathy
DOI:
https://doi.org/10.9771/cmbio.v13i1.9024Keywords:
Diabetic retinopathy. Off-label use. Therapy. Diabetes mellitus.Abstract
Introduction: The prescribing a drug without the indications for which the drug was originally approved by regulators is internationally known as prescribing “off-label”. Objective: To describe the off-label therapy in diabetic retinopathy, reported international scientific literature, through an integrative bibliographical review. Method: Integrative review by searching the Medline international database for review of manuscripts. Results: A total 852 scientific productions were identified, and 37 studies were selected by contain information about the off-label therapy in diabetic retinopathy. Conclusion: The practice of off-label prescribing in diabetic retinopathy has benefits, and in some situations is the only treatment available.
Downloads
Download data is not yet available.
Downloads
Published
2014-07-21
How to Cite
de Oliveira Andrade, L. J., Santos França, L., Santos França, L., Vinhaes Bittencourt, A. M., & Santos França, C. (2014). Off-label treatment in diabetic retinopathy. Journal of Medical and Biological Sciences, 13(1), 78–84. https://doi.org/10.9771/cmbio.v13i1.9024
Issue
Section
Review Articles
License
The Journal of Medical and Biological Sciences reserves all copyrights of published works, including translations, allowing, however, their subsequent reproduction as transcription, with proper citation of source, through the Creative Commons license. The periodical has free and free access.
